Reuters -- Belgian chemicals firm Solvay surprised investors with a 356 million euro share buyback but said it still plans to use a 1.7 billion euro ($2.3 billion) gain from the sale of its drugs unit to finance acquisitions.
Reuters -- Belgian chemicals firm Solvay surprised investors with a 356 million euro share buyback but said it still plans to use a 1.7 billion euro ($2.3 billion) gain from the sale of its drugs unit to finance acquisitions.
